TLX 1.54% $20.44 telix pharmaceuticals limited

Forecasting Quarterly Sales Figures, page-60

  1. 1,774 Posts.
    lightbulb Created with Sketch. 768
    if

    Valuation. Newprice target of $10.35 per share equates to 20x FY23e revenue (WILSe:A$145M). Obvious caveats include major market approvals for ILLUCCIX which isthe sole current source of revenue in our model. Our unrisked PT stands at$14.00 per share. Pipeline assets (TLX250, TLX66, TLX101) account for 11% ofour risked SOTP valuation.


    back of envelope stuff

    22m for ten weeks then 26 m for twelve weeks or 104m per year
    big uplift from july 1 , say 25%

    makes annual circa $A145 pretty accurate
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.